Merit Medical Systems, Inc. (MMSI)
USD 92.48
(1.02%)
USD 92.48
(1.02%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.12 Billion USD | 116.19% |
| 2022 | 519.56 Million USD | -14.61% |
| 2021 | 608.49 Million USD | -13.79% |
| 2020 | 705.82 Million USD | -12.58% |
| 2019 | 807.37 Million USD | 17.48% |
| 2018 | 687.23 Million USD | 57.81% |
| 2017 | 435.47 Million USD | -2.06% |
| 2016 | 444.61 Million USD | 42.22% |
| 2015 | 312.62 Million USD | 0.23% |
| 2014 | 311.9 Million USD | -3.31% |
| 2013 | 322.57 Million USD | -0.36% |
| 2012 | 323.73 Million USD | 259.99% |
| 2011 | 89.92 Million USD | -32.82% |
| 2010 | 133.86 Million USD | 153.99% |
| 2009 | 52.7 Million USD | 40.65% |
| 2008 | 37.47 Million USD | 3.94% |
| 2007 | 36.05 Million USD | 14.61% |
| 2006 | 31.45 Million USD | 5.69% |
| 2005 | 29.76 Million USD | 3.25% |
| 2004 | 28.82 Million USD | 51.26% |
| 2003 | 19.05 Million USD | 27.84% |
| 2002 | 14.9 Million USD | -21.55% |
| 2001 | 19 Million USD | -48.19% |
| 2000 | 36.67 Million USD | -7.62% |
| 1999 | 39.7 Million USD | 88.15% |
| 1998 | 21.1 Million USD | 10.47% |
| 1997 | 19.1 Million USD | 1.6% |
| 1996 | 18.8 Million USD | 25.33% |
| 1995 | 15 Million USD | 59.57% |
| 1994 | 9.4 Million USD | 95.83% |
| 1993 | 4.8 Million USD | 54.84% |
| 1992 | 3.1 Million USD | 47.62% |
| 1991 | 2.1 Million USD | 200.0% |
| 1990 | 700 Thousand USD | 16.67% |
| 1989 | 600 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.05 Billion USD | -3.19% |
| 2024 Q1 | 1.08 Billion USD | -3.3% |
| 2024 Q2 | 1.08 Billion USD | 0.3% |
| 2023 FY | 1.12 Billion USD | 116.19% |
| 2023 Q4 | 1.12 Billion USD | 94.12% |
| 2023 Q1 | 512.45 Million USD | -1.37% |
| 2023 Q2 | 633.86 Million USD | 23.69% |
| 2023 Q3 | 578.62 Million USD | -8.72% |
| 2022 FY | 519.56 Million USD | -14.61% |
| 2022 Q2 | 558.21 Million USD | -2.62% |
| 2022 Q4 | 519.56 Million USD | -4.47% |
| 2022 Q3 | 543.89 Million USD | -2.56% |
| 2022 Q1 | 573.22 Million USD | -5.8% |
| 2021 Q2 | 649.95 Million USD | -3.71% |
| 2021 FY | 608.49 Million USD | -13.79% |
| 2021 Q4 | 608.49 Million USD | -3.38% |
| 2021 Q3 | 629.79 Million USD | -3.1% |
| 2021 Q1 | 675.02 Million USD | -4.36% |
| 2020 FY | 705.82 Million USD | -12.58% |
| 2020 Q1 | 809.47 Million USD | 0.26% |
| 2020 Q4 | 705.82 Million USD | -4.19% |
| 2020 Q3 | 736.67 Million USD | -6.4% |
| 2020 Q2 | 787.02 Million USD | -2.77% |
| 2019 Q4 | 807.37 Million USD | -0.63% |
| 2019 Q1 | 749.68 Million USD | 9.09% |
| 2019 Q3 | 812.46 Million USD | 3.73% |
| 2019 Q2 | 783.23 Million USD | 4.48% |
| 2019 FY | 807.37 Million USD | 17.48% |
| 2018 Q4 | 687.23 Million USD | 77.73% |
| 2018 Q2 | 591.93 Million USD | 7.83% |
| 2018 Q3 | 386.67 Million USD | -34.68% |
| 2018 Q1 | 548.94 Million USD | 26.06% |
| 2018 FY | 687.23 Million USD | 57.81% |
| 2017 Q2 | 385.36 Million USD | 6.21% |
| 2017 Q4 | 435.47 Million USD | 3.6% |
| 2017 FY | 435.47 Million USD | -2.06% |
| 2017 Q1 | 362.83 Million USD | -18.39% |
| 2017 Q3 | 420.33 Million USD | 9.07% |
| 2016 Q2 | 334.97 Million USD | 1.17% |
| 2016 Q1 | 331.09 Million USD | 5.91% |
| 2016 Q3 | 442.81 Million USD | 32.19% |
| 2016 FY | 444.61 Million USD | 42.22% |
| 2016 Q4 | 444.61 Million USD | 0.41% |
| 2015 Q4 | 312.62 Million USD | 1.02% |
| 2015 Q1 | 297.32 Million USD | -4.68% |
| 2015 FY | 312.62 Million USD | 0.23% |
| 2015 Q3 | 309.48 Million USD | 2.37% |
| 2015 Q2 | 302.32 Million USD | 1.68% |
| 2014 FY | 311.9 Million USD | -3.31% |
| 2014 Q4 | 311.9 Million USD | -3.21% |
| 2014 Q3 | 322.25 Million USD | -1.82% |
| 2014 Q2 | 328.21 Million USD | -1.19% |
| 2014 Q1 | 332.18 Million USD | 2.98% |
| 2013 Q3 | 322.55 Million USD | -4.8% |
| 2013 Q4 | 322.57 Million USD | 0.01% |
| 2013 FY | 322.57 Million USD | -0.36% |
| 2013 Q1 | 328.8 Million USD | 1.57% |
| 2013 Q2 | 338.83 Million USD | 3.05% |
| 2012 Q4 | 323.73 Million USD | 134.33% |
| 2012 FY | 323.73 Million USD | 259.99% |
| 2012 Q2 | 129.6 Million USD | 3.18% |
| 2012 Q1 | 125.61 Million USD | 39.68% |
| 2012 Q3 | 138.15 Million USD | 6.6% |
| 2011 Q2 | 111.9 Million USD | -16.24% |
| 2011 Q4 | 89.92 Million USD | 32.02% |
| 2011 FY | 89.92 Million USD | -32.82% |
| 2011 Q1 | 133.6 Million USD | -0.2% |
| 2011 Q3 | 68.11 Million USD | -39.13% |
| 2010 Q3 | 134.19 Million USD | 167.5% |
| 2010 FY | 133.86 Million USD | 153.99% |
| 2010 Q2 | 50.16 Million USD | -5.92% |
| 2010 Q1 | 53.32 Million USD | 1.17% |
| 2010 Q4 | 133.86 Million USD | -0.25% |
| 2009 Q3 | 52.54 Million USD | -0.37% |
| 2009 Q4 | 52.7 Million USD | 0.31% |
| 2009 FY | 52.7 Million USD | 40.65% |
| 2009 Q2 | 52.73 Million USD | 21.69% |
| 2009 Q1 | 43.33 Million USD | 15.65% |
| 2008 Q4 | 37.47 Million USD | -5.54% |
| 2008 Q2 | 39.98 Million USD | 0.46% |
| 2008 Q3 | 39.67 Million USD | -0.78% |
| 2008 FY | 37.47 Million USD | 3.94% |
| 2008 Q1 | 39.79 Million USD | 10.39% |
| 2007 Q3 | 34.87 Million USD | -3.21% |
| 2007 Q4 | 36.05 Million USD | 3.37% |
| 2007 Q2 | 36.03 Million USD | 3.2% |
| 2007 Q1 | 34.91 Million USD | 11.0% |
| 2007 FY | 36.05 Million USD | 14.61% |
| 2006 Q3 | 31.73 Million USD | -1.4% |
| 2006 FY | 31.45 Million USD | 5.69% |
| 2006 Q1 | 30.18 Million USD | 1.43% |
| 2006 Q2 | 32.18 Million USD | 6.62% |
| 2006 Q4 | 31.45 Million USD | -0.88% |
| 2005 Q2 | 31.13 Million USD | 0.76% |
| 2005 FY | 29.76 Million USD | 3.25% |
| 2005 Q4 | 29.76 Million USD | -3.76% |
| 2005 Q3 | 30.92 Million USD | -0.66% |
| 2005 Q1 | 30.89 Million USD | 7.19% |
| 2004 Q2 | 24.83 Million USD | 18.84% |
| 2004 Q1 | 20.9 Million USD | 9.68% |
| 2004 FY | 28.82 Million USD | 51.26% |
| 2004 Q3 | 23.14 Million USD | -6.81% |
| 2004 Q4 | 28.82 Million USD | 24.52% |
| 2003 Q2 | 18.34 Million USD | 7.35% |
| 2003 Q4 | 19.05 Million USD | -2.59% |
| 2003 Q3 | 19.56 Million USD | 6.66% |
| 2003 FY | 19.05 Million USD | 27.84% |
| 2003 Q1 | 17.08 Million USD | 14.62% |
| 2002 FY | 14.9 Million USD | -21.55% |
| 2002 Q1 | 15.96 Million USD | -15.96% |
| 2002 Q4 | 14.9 Million USD | -5.9% |
| 2002 Q3 | 15.84 Million USD | 2.94% |
| 2002 Q2 | 15.38 Million USD | -3.62% |
| 2001 FY | 19 Million USD | -48.19% |
| 2001 Q1 | 34.18 Million USD | -6.78% |
| 2001 Q3 | 23.83 Million USD | -19.36% |
| 2001 Q2 | 29.55 Million USD | -13.56% |
| 2001 Q4 | 19 Million USD | -20.27% |
| 2000 Q2 | 42.63 Million USD | 2.51% |
| 2000 Q1 | 41.58 Million USD | 4.76% |
| 2000 FY | 36.67 Million USD | -7.62% |
| 2000 Q4 | 36.67 Million USD | -9.95% |
| 2000 Q3 | 40.72 Million USD | -4.47% |
| 1999 Q2 | 23.5 Million USD | 4.91% |
| 1999 Q3 | 37.4 Million USD | 59.15% |
| 1999 FY | 39.7 Million USD | 88.15% |
| 1999 Q4 | 39.7 Million USD | 6.15% |
| 1999 Q1 | 22.4 Million USD | 6.16% |
| 1998 Q1 | 19.1 Million USD | 0.0% |
| 1998 FY | 21.1 Million USD | 10.47% |
| 1998 Q2 | 18.4 Million USD | -3.66% |
| 1998 Q3 | 19.6 Million USD | 6.52% |
| 1998 Q4 | 21.1 Million USD | 7.65% |
| 1997 Q2 | 18.6 Million USD | 0.54% |
| 1997 Q1 | 18.5 Million USD | -1.6% |
| 1997 Q3 | 19.4 Million USD | 4.3% |
| 1997 Q4 | 19.1 Million USD | -1.55% |
| 1997 FY | 19.1 Million USD | 1.6% |
| 1996 Q4 | 18.8 Million USD | 18.24% |
| 1996 Q2 | 16.6 Million USD | 5.73% |
| 1996 Q1 | 15.7 Million USD | 4.67% |
| 1996 FY | 18.8 Million USD | 25.33% |
| 1996 Q3 | 15.9 Million USD | -4.22% |
| 1995 Q3 | 12.4 Million USD | -3.13% |
| 1995 Q4 | 15 Million USD | 20.97% |
| 1995 Q1 | 10.3 Million USD | 9.57% |
| 1995 Q2 | 12.8 Million USD | 24.27% |
| 1995 FY | 15 Million USD | 59.57% |
| 1994 Q1 | 7.4 Million USD | 54.17% |
| 1994 FY | 9.4 Million USD | 95.83% |
| 1994 Q4 | 9.4 Million USD | 17.5% |
| 1994 Q3 | 8 Million USD | 2.56% |
| 1994 Q2 | 7.8 Million USD | 5.41% |
| 1993 Q1 | 3.3 Million USD | 6.45% |
| 1993 Q3 | 3.8 Million USD | 35.71% |
| 1993 FY | 4.8 Million USD | 54.84% |
| 1993 Q4 | 4.8 Million USD | 26.32% |
| 1993 Q2 | 2.8 Million USD | -15.15% |
| 1992 FY | 3.1 Million USD | 47.62% |
| 1992 Q1 | 2.6 Million USD | 23.81% |
| 1992 Q2 | 2.8 Million USD | 7.69% |
| 1992 Q3 | 2.8 Million USD | 0.0% |
| 1992 Q4 | 3.1 Million USD | 10.71% |
| 1991 Q3 | 1.2 Million USD | 0.0% |
| 1991 FY | 2.1 Million USD | 200.0% |
| 1991 Q4 | 2.1 Million USD | 75.0% |
| 1990 FY | 700 Thousand USD | 16.67% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1989 Q4 | 600 Thousand USD | 0.0% |
| 1989 FY | 600 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -787.246% |
| AngioDynamics, Inc. | 112.08 Million USD | -902.136% |
| AtriCure, Inc. | 147.76 Million USD | -660.161% |
| Avinger, Inc. | 19.97 Million USD | -5524.094% |
| Azenta, Inc. | 351.22 Million USD | -219.812% |
| BioLife Solutions, Inc. | 75.05 Million USD | -1396.641% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 72.656% |
| Daxor Corporation | 858.75 Thousand USD | -130698.665% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -6785.998% |
| Femasys Inc. | 9.4 Million USD | -11845.292% |
| GlucoTrack, Inc. | 1.7 Million USD | -65663.7% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -1647.098% |
| Hologic, Inc. | 4.02 Billion USD | 72.1% |
| ICU Medical, Inc. | 2.25 Billion USD | 50.189% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 45.052% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -13754.893% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -2198.056% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -170104.99% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -170104.99% |
| Masimo Corporation | 1.67 Billion USD | 33.009% |
| Microbot Medical Inc. | 3.82 Million USD | -29258.181% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -4379.1% |
| Nephros, Inc. | 3.5 Million USD | -31965.201% |
| NovoCure Limited | 783.63 Million USD | -43.338% |
| NEXGEL, Inc. | 4.78 Million USD | -23354.667% |
| NEXGEL, Inc. | 4.78 Million USD | -23354.667% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -1199.134% |
| OraSure Technologies, Inc. | 52.17 Million USD | -2052.881% |
| Pro-Dex, Inc. | 23.34 Million USD | -4711.909% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -6730.723% |
| Predictive Oncology Inc. | 6.14 Million USD | -18177.596% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -16310.214% |
| QuidelOrtho Corporation | 3.55 Billion USD | 68.423% |
| Repligen Corporation | 853.2 Million USD | -31.649% |
| Sanara MedTech Inc. | 29.28 Million USD | -3735.806% |
| STAAR Surgical Company | 102.73 Million USD | -993.309% |
| Sharps Technology, Inc. | 3.85 Million USD | -29037.464% |
| Utah Medical Products, Inc. | 7.14 Million USD | -15620.7% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 72.442% |
| Jin Medical International Ltd. | 8.92 Million USD | -12486.291% |